Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2009-02-24
2010-02-16
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C424S451000
Reexamination Certificate
active
07662858
ABSTRACT:
A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
REFERENCES:
patent: 6287594 (2001-09-01), Wilson et al.
patent: 6365180 (2002-04-01), Meyer et al.
patent: 6974595 (2005-12-01), Reiner et al.
patent: WO 2006/017354 (2006-02-01), None
Hinz et al (Brit J Clin Pharmacol 59:80-84, 2004).
Millar et al (Practical Anaesthesia and Analgesia for Day Surgery, p. 160, 1997).
Desjardins, et al “A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain”,Current Medical Research and Opinions, vol. 20, No. 10, pp. 1523-1537 (2004).
Hersh, et al., “Dose-Ranging Analegesic Study of ProSorb® Diclofenac Potassium in Postsurgical Dental Pain”,Clinical Therapeutics, vol. 26, No. 8, pp. 1215-1227, (2004).
Hofele, et al., “Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo-controlled, randomized, comparative study vs. diclofenac potassium tablets”,J. Clin. Pract., vol. 60, No. 3, pp. 300-307, (2006).
Marzo, et al., “Pharmacokinetics of Diclofenac after Oral Administration of its Potassium Salt in Sachet and Tablet Formulations”,Arzneim-Forsch./Drug Res., Vol. 50, No. 1, pp. 43-47, (2000).
Moore al., “Pharmacokinetics of a novel liquid-gel formulation of diclofenac potassium”,The Journal of Pain, vol. 9, No. 4, p. 33, Abstract No. 230 (2008).
Moore, et al., “Pharmacokinetics of a novel liquid-gel formulation of diclofenac potassium”, May 2008 Poster presented at the 2008 American Pain Society (APS) 27thAnnual Scientific Meeting, Tampa, Florida, USA.
Reiner, et al., “Increased Absorption Rate of Disclofenac from Fast Acting Formulations Containing its Potassium Salt”,Arzneim-Forsch./Drug Res., vol. 51, pp. 885-890, (2001).
Zuniga, “Analgesic Safety and Efficacy of Diclofenac Sodium Softgels on Postoperative Third Molar Extraction Pain”J. Oral Maxillofac. Surg., vol. 62, pp. 806-815, (2004).
U.S. Appl. No. 12/466,491, filed May 15, 2009, Kowalski et al.
Breivik, et al. “Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study”,Clin. Phann.&Ther, vol. 66, No. 6, pp. 625-635, (1999).
Cepeda, et al. “What decline in pain intensity is meaningful to patients with acute pain?”,Pain, vol. 105, pp. 151-157, (2003).
Breivik, et al., “Assessment of Pain”,B. J. of Anesth., vol. 101, No. 1, pp. 17-24, (2008).
Cataflam® (diclofenac potassium immediate-release tablets) drug label,Novartis, pp. 1-16, revised (2009).
Hinz, et al., “Bioavailability of diclofenac potassium at low doses”,B. J. Of Clin. Pharm., vol. 59, No. 1, pp. 80-84, (2005).
Lasagna, et al., “Further Studies on the ‘Pharmacology’ of Placebo Administration”,J. Clin. Invest, vol. 37, No. 4, pp. 533-537, (1958).
Laska, et al., “The correlation between blood levels of ibuprofen and clinical analgesic response”,Clin. Pharmacol. &Ther., vol. 40, No. 1, pp. 1-7, (1986).
Lötsch, et al., “Population Pharmacokinetics of Fast Release Oral Diclofenac in Healthy Volunteers: Relation to Pharmacodynamics in an Experimental Pain Model”,Pharma. Res., vol. 17, No. 1, pp. 77- 83, (2000).
Maciá, et al., “Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks”,Int'l J. of Clin. Pharma. And Therap., vol. 33, No. 6, pp. 333-339, (1995).
Mitchell, et al. “Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible”Proc. Natl. Acad. Sci. USA, vol. 90, pp. 11693-11697, (1994).
Riad, et al., “Effect of Food on the Multiple-Peak Behavior After a Single Oral Dose of Diclofenac Sodium Slow-Release Tablet in Humans”,Amer. J. of Therap., vol. 2, pp. 237-242, (1995).
Schmidt, et al., “Analgesic Onset of a Novel Liquid Gel Formulation of Diclofenac Potassium in Post-Surgical Dental Pain”,The Journal of Pain, vol. 9, No. 4, p. 33, Abstract No. 231, (2008).
Schmidt, et al., “Analgesic Onset of a Novel Liquid Gel Formulation of Diclofenac Potassium in Post-Surgical Dental Pain”, May 2008 Poster presented at the 2008 American Pain Society (APS) 27thAnnual Scientific Meeting. Tampa. Florida. USA.
Seymour, et al., “An evaluation of different ibuprofen preparations in the control of postoperative pain after third molar surgery”,B. J. Clin. Pharmacol., vol. 31, pp. 83-87, (1991).
Terhaag, et al., “Bioavailability of a new effervescent tablet of diclofenac”Int'l J. Of Clin. Pharm. and Therap., vol. 38, No. 11, pp. 546-551, (2000).
Kowalski Mark M.
Moore Keith A.
Young James L.
aaiPharma, Inc.
Marschel Ardin
McDonnell Boehnen & Hulbert & Berghoff LLP
Ricci Craig
LandOfFree
Method of treating post-surgical acute pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating post-surgical acute pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating post-surgical acute pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177755